Anti-counterfeit Pharmaceutical Packaging Market Size & Share, by Technology (RFID, Holograms, Tamper-Evident Seals, Barcode); Application; Region- Global Supply & Demand Analysis, Growth Forecasts, Statistical Report 2025-2037

Anti-counterfeit Pharmaceutical Packaging Market - Growth Drivers and Challenges

Growth Drivers

• Regulatory mandates and government support: Governments play a significant role within the global platform to reduce the risk of counterfeit products by strengthening the regulation of packaging. According to the report of the FDA’s Drug Supply Chain Security Act, full serialization of the drugs has been made mandatory, and a budget of over USD 1 billion has been invested to enforce the regulation. More than 18% growth of adoption for anti-counterfeit pharmaceutical packaging has been advocated by the EU’s Falsified Medicines Directive. Spending for safe packaging has also been expanded to more than USD 800 billion within the Medicare Spending to minimize counterfeit activities.  

• Rising cases of counterfeit drugs: According to the report published by the World Health Organization, 11% of the total global medicine has undergone the unethical act of counterfeiting. This has resulted in the health care system bearing a cost of more than USD 195 billion each year. Treatment costs within the hospital of U.S. hospitals have also increased by USD 5.5 billion according to the evaluation conducted by AHARQ. This has created a significant demand for anti-counterfeit pharmaceutical packaging, which will be an adequate alternative to reduce the cost by nearly 32%.  

Key Market Dynamics for Historical Patient Growth

The anti-counterfeit pharmaceutical packaging has shaped the market towards growth within the time span of 2010-2020. Steady growth within the markets of the U.S., Germany, and Japan has been witnessed within the global platform. Emerging economy and betterment within the regulatory system have been the key aspects which led to the historical growth of the concerned market. As per the market study of the Drug Supply Chain Security Act, patients' reliance on authentic medicines has increased at a rate of 5.4% in the U.S. These aspects have created a potential demand pool scenario within the global market for anti-counterfeit pharmaceutical packaging.

The following table denotes historical patient growth in the past ten years across different countries:

Key Feasibility Models for Anti-counterfeit Pharmaceutical Packaging Market Expansion

The three core strategies that have led the market to expand within the global region are technological partnership, regulatory approach, and market customization. Partnership with a firm with blockchain and AI assistance has elevated the track-and-trace ability of the packaging. Firms from the U.S. and the EU have exhibited alignment with the regulatory approaches and have entered long-term contracts. The company has taken the strategy of delivering cost-effective products like holograms and barcodes for the markets of China and India, ensuring business escalation.

Strategic Models Revenue Impact 2014-2024

Challenges

• Government pricing and barriers to reimbursement: The cost of manufacturing anti-counterfeit pharmaceutical packaging is higher compared to the traditional methods. Each unit costs approximately USD 1.50. The U.S. Medicaid coverage for the anti-counterfeit pharmaceutical packaging solution is less than 38%, creating a barrier for low-income consumers to access the drugs. Over 15% reduction in EU price caps for the manufacturer's margin crippled the profit margin rate for the companies and negotiation on the bulk deals were conducted.

• Barriers of Regulation delay: The complex and frequent changes in the regulatory standard for packaging have created a delay in the process. For instance, PMDS of Japan has experienced a delay in approval for six new anti-counterfeit pharmaceutical packaging. This has led to the firm bearing a loss of more than USD 24 million. A complex issue is addressed by global businesses as per the differentiation of compliance between U.S. and EU regulations. This creates a barrier for the business to easily penetrate the market and launch their new product to gain higher revenue.